Cita APA

Furlow, B. (2020). COVACTA trial raises questions about tocilizumab's benefit in COVID-19. Lancet Rheumatol.

Chicago Style Citation

Furlow, Bryant. "COVACTA Trial Raises Questions About Tocilizumab's Benefit in COVID-19." Lancet Rheumatol 2020.

Cita MLA

Furlow, Bryant. "COVACTA Trial Raises Questions About Tocilizumab's Benefit in COVID-19." Lancet Rheumatol 2020.

Atenció: Aquestes cites poden no estar 100% correctes.